摘要 |
The invention relates to the use of glycosidase inhibitors selected from compounds of general formula (1), wherein R<SUB>1 </SUB>represents a CH<SUB>3 </SUB>group, or CH<SUB>2</SUB>OH, R<SUB>2 </SUB>represents H or an alkyl group having 1-5 carbon atoms, or R<SUB>1 </SUB>and R<SUB>2 </SUB>together form a group having formula (II), with carbon in position (a) and nitrogen of formula (I) mentioned above, for the preparation of a medicament used to treat mucoviscidosis.
|